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Abstract
Background: This is a follow-up study to evaluate and improve quality health care for the majority of the population in
Bloemfontein. The aim of this study was to evaluate the changes implemented to address the cost of prescribing drugs
at National District Hospital, Bloemfontein as described in a previous study
Methods: The 20 most expensive or inappropriate prescribed drugs were identified from the results of the first study.
These drugs were grouped together in order to address the problems systematically, e.g. revising and updating the
current treatment protocols for chronic conditions and using cheaper alternatives. Three months after the implementation
of the new measures, the affected drugs were re-evaluated over an eight-week period.
Results: A total of 28 drugs (the 20 drugs + eight drugs on which they may have a direct influence) was evaluated over
an eight-week period. The introduction of the treatment protocols not only saved a large amount of money, but also
made prescribers aware of the correct dosages of the drugs. A saving of R215 395 in the dispensing of medicine in eight
weeks was demonstrated. A massive calculated saving of R1.4 million could be achieved over a one-year period at NDH
with adherence to the saving measures.
Conclusion: Drug costs can be substantially reduced through review of drug use and introduction of protocols and
guidelines.         (SA Fam Pract 2005;47(9): 60-62)
Background
A cost-conscious approach to
prescribing will help to make therapy
more affordable for patients1 and the
public sector. In a previous study, the
cost  of  pr imary heal th care
prescriptions was evaluated and
problem areas were identified.2 In that
study, 1 000 prescriptions at both the
Heidedal Community Health Centre
and the National District Hospital
(NDH) in Bloemfontein were evaluated
over two-month periods. The average
number of items per script was 3.1
and 4.1 respectively, and the average
cost per script R11.04 and R64.08
respectively.
The aim of this study was to
evaluate the changes implemented to
address the cost of prescribing drugs
at NDH, as described in a previous
study.2
Method
From the results of the first study, the
20 most expensive or inappropriate
prescribed drugs were identified. The
problems identified by the previous
study2 were:
1. Hypertension treatment and follow-
up and the use of anti-hypertensive
drugs
2. Different types of insulin and
diabetes monitoring
3. Gastrointestinal drugs
4. Drugs prescribed that were not on
the Essential Drug List (EDL)3
5. Number of tablets prescribed for
acute conditions, e.g. pain tablets
6. Repeat prescriptions in which
acute or non-urgent drugs were
also repeated
7. Drugs prescribed when cheaper
or better alternatives were available
on the EDL
These problems were grouped
together in order to address them
systematically. Each group of problems
was then addressed according to the
specific problem. The following general
guidelines were given:
1. Do not treat side effects with
drugs.1
2. Every prescriber must take
responsibility for every drug that is
prescribed.1
3. Beware of drug interactions.1
4. Try to reduce the number of items
per script.4
5. Do not prescribe drugs not in the
EDL.5
With regard to acute conditions, the
following instructions were given:
1. Limit the number of pain tablets,
e.g. limit paracetamol tablets to 10
and nonsteroidal anti- inflammatory
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drugs (NSAIDs) to 15.
2. Seek cheaper alternatives, e.g.
sennosides vs. liquid paraffin
(R1,30 vs. R3, 23); ketoconazole
oral gel (R42,74) vs. Diflucan® (free).6
3. Reconsider the use of non-urgent
drugs, e.g. fibre stool softeners at
R57 421/year.
Guidelines for chronic conditions
included that:
1. Prescribers had to stick to treat-
ment protocols.7
2. The use of patient carry cards had
to be implemented.
3. The cheapest angiotensin-
converting enzyme inhibitor (ACE
inhibitor) (enalapril vs. perindopril)
had to be used. This matter was
referred to the Provincial Thera-
peutic Committee (PTC), which
approved the cheaper ACE
inhibitor.8
4. Patients should not receive any
premixed unit dose vials (UDVs)
for home nebulisation, but had to
be taught how to use a metered
dose inhaler (MDI) with a spacer.9
5. Proton pump inhibitors (PPIs)
(omeprozole) and lipid-lowering
drugs (atorvastatin) should be
referred to the PTC. The PTC
approved specific treatment
protocols for these drugs.10
6. Patients on insulin who were able
to use vials should be switched to
vials instead of pen sets. The PTC
later approved this policy for the
Province.11
Revised and updated treatment
protocols for chronic conditions were
re-introduced to all healthcare
professionals. Patient carry cards were
implemented for patients with chronic
conditions. All this information was
communicated to the doctors and the
rest of the Free State province via
lectures on ICAM (interactive
communication with audio-video
methods). Notices on brightly coloured
paper were displayed in the clinics to
reemphasise the savings measures to
the doctors and the patients.
Supervisors in the clinics did in-service
training. The pharmacy personnel
cooperated well by informing the
prescribers of anything prescribed
that was not in accordance with the
savings measures. The effect of the
savings measures was monitored
continuously and problems were
addressed immediately. Matters of
importance to the whole province were
referred to the PTC, which can change
provincial policy.
Three months after the implemen-
tation of the new measures, the 20
most expensive or inappropriate
prescribed items  were re-evaluated
over an eight-week period. Eight
drugs, in the same class or that could
be used as substitutes for the 20
drugs, were also evaluated to see the
impact of the changes on these drugs.
The pharmacy cards (a daily stock
record card) of the specific drugs were
used to establish the exact number of
drugs dispensed during the eight-
week period. These figures were
compared with the average number
of drugs dispensed in the 52 weeks
that preceded the implementation of
the new measures. Seasonal variation
does not play a major role in the drugs
evaluated.
Results
Table I lists the drugs evaluated in this
study.
Table II demonstrates the effects
of the savings measures in relation to
the drugs prescribed for gastro-
intestinal conditions during the eight-
Table I: Drugs evaluated in the study









Liquid paraffin Sennosides A and B
Ispaghula husk powder
Pre-mixed 30/70 insulin pen set             Pre-mixed 30/70 insulin vials






B2 nebulising fluid (UDVs)  Salbutamol metered dose inhalers
Ipratropium bromide (UDVs) Ipratropium bromide metered dose inhalers
Ciprofloxacin hydrochloride
Ketoconazole oral gel
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week period. Patients had to be given
a gastroscopy before PPIs were
prescribed, and then the drugs were
prescribed for a limited period only.
The indications for fibre stool softeners
were also restricted.
Table III demonstrates the effect of
the saving measures on the drugs for
chronic conditions. Insulin pen sets
were replaced with insulin vials when
indicated and glucostix were only
prescribed if the patient knew how to
use them and adjust his or her
treatment accordingly. The use of
UDVs was limited to the minimum, as
home nebulisation with B2 stimulants
or ipratropium bromide UDVs is not
superior to correctly metered dose
inhalers.9
Table IV demonstrates the effects
of the saving measures on drugs
prescribed for acute conditions. When
prescribing antibiotics for specific
conditions, prescribers had to follow
guidelines according to the EDL. The
number of pain tablets for the treatment
of acute conditions was reduced to
10 or 15 instead of the pre-packed 30
to 90 tablets.
During the eight-week audit, there
was a decrease of R215 395 in the
cost of the medicines that were
dispensed. This means that R1.4




regarding prescribing methods were
stressed during the introduction of the
saving measures. In patients with
chronic conditions, patient care and
satisfaction improved with the
implementation of the patient carry
cards and revised treatment protocols.
From the carry cards it was possible
to monitor adherence, the following of
protocols and disease control better,
and the patients took more responsi-
bility for their diseases. An interesting
aspect that is illustrated in Table II is
the reduction in the use of all laxatives
with the introduction of the savings
measures for fibre stool softeners. The
change from perindopril to enalapril,
the cheaper alternative, saved a lot of
money and it would have been
possible to save a further R142 295.20
on the remainder of the perindopril
stock in the hospital had enalapril been
used instead of perindopril. The
change from the insulin pen sets to
the insulin vials and the introduction
of the treatment protocols for diabetes
not only saved a lot of money, but also
made the prescribers aware of the
correct dosages of insulin and how to
calculate the number of vials
accurately.
The prescribing of two schedule-
5 drugs, hydroxyzine (used for sleep
disorders) and imipramine (used for
depression), which were not on the
EDL for primary health care use, were
stopped without any influence on the
available drug, amitriptyline.
Conclusion
Drug costs can be substantially
reduced through a review of drug use
and the introduction of protocols and
guidelines.
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in the 8 weeks
(R)
1 562
No effect
4 521
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